These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 15221370)

  • 1. Consistency of staining and reporting of oestrogen receptor immunocytochemistry within the European Union--an inter-laboratory study.
    Wells CA; Sloane JP; Coleman D; Munt C; Amendoeira I; Apostolikas N; Bellocq JP; Bianchi S; Boecker W; Bussolati G; Connolly CE; Dervan P; Drijkoningen M; Ellis IO; Elston CW; Eusebi V; Faverly D; Heikkila P; Holland R; Jacquemier J; Lacerda M; Martinez-Penuela J; De Miguel C; Peterse JL; Rank F; Reiner A; Saksela E; Sigal-Zafrani B; Sylvan M; Borisch B; Cserni G; Decker T; Kerner H; Kulka J; Regitnig P; Sapino A; Tanous AM; Thorstenson S; Zozaya E;
    Virchows Arch; 2004 Aug; 445(2):119-28. PubMed ID: 15221370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical demonstration of oestrogen and progesterone receptors: correlation of standards achieved on in house tumours with that achieved on external quality assessment material in over 150 laboratories from 26 countries.
    Rhodes A; Jasani B; Balaton AJ; Miller KD
    J Clin Pathol; 2000 Apr; 53(4):292-301. PubMed ID: 10823126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality assurance for detection of estrogen and progesterone receptors by immunohistochemistry in Austrian pathology laboratories.
    Regitnig P; Reiner A; Dinges HP; Höfler G; Müller-Holzner E; Lax SF; Obrist P; Rudas M; Quehenberger F
    Virchows Arch; 2002 Oct; 441(4):328-34. PubMed ID: 12404057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multinational study of oestrogen and progesterone receptor immunocytochemistry on breast carcinoma fine needle aspirates.
    Marinšek ZP; Nolde N; Kardum-Skelin I; Nizzoli R; Onal B; Rezanko T; Tani E; Ostović KT; Vielh P; Schmitt F; Kocjan G
    Cytopathology; 2013 Feb; 24(1):7-20. PubMed ID: 23082931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of interlaboratory variation in the immunohistochemical determination of estrogen receptor status using a breast cancer tissue microarray.
    Parker RL; Huntsman DG; Lesack DW; Cupples JB; Grant DR; Akbari M; Gilks CB
    Am J Clin Pathol; 2002 May; 117(5):723-8. PubMed ID: 12090420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the oestrogen and progesterone receptor status in primary breast carcinomas as evaluated by immunohistochemistry and immunocytochemistry: a consecutive series of 267 patients.
    Domanski AM; Monsef N; Domanski HA; Grabau D; Fernö M
    Cytopathology; 2013 Feb; 24(1):21-5. PubMed ID: 22783929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Highly reproducible results of breast cancer biomarkers when analysed in accordance with national guidelines - a Swedish survey with central re-assessment.
    Ekholm M; Grabau D; Bendahl PO; Bergh J; Elmberger G; Olsson H; Russo L; Viale G; Fernö M
    Acta Oncol; 2015 Jul; 54(7):1040-8. PubMed ID: 25959664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased use of immunohistochemistry for oestrogen receptor measurement in mammary carcinoma: the need for quality assurance.
    Barnes DM; Millis RR; Beex LV; Thorpe SM; Leake RE
    Eur J Cancer; 1998 Oct; 34(11):1677-82. PubMed ID: 9893651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reliability of immunohistochemical demonstration of oestrogen receptors in routine practice: interlaboratory variance in the sensitivity of detection and evaluation of scoring systems.
    Rhodes A; Jasani B; Barnes DM; Bobrow LG; Miller KD
    J Clin Pathol; 2000 Feb; 53(2):125-30. PubMed ID: 10767828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormone receptor expression in breast cancer: postanalytical issues.
    Lee M; Lee CS; Tan PH
    J Clin Pathol; 2013 Jun; 66(6):478-84. PubMed ID: 23526546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality control in immunocytochemistry: experiences with the oestrogen receptor assay.
    Bosman FT; de Goeij AF; Rousch M
    J Clin Pathol; 1992 Feb; 45(2):120-4. PubMed ID: 1541691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interobserver concordance in implementing the 2010 ASCO/CAP recommendations for reporting ER in breast carcinomas: a demonstration of the difficulties of consistently reporting low levels of ER expression by manual quantification.
    Reisenbichler ES; Lester SC; Richardson AL; Dillon DA; Ly A; Brock JE
    Am J Clin Pathol; 2013 Oct; 140(4):487-94. PubMed ID: 24045544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The reliability of assessment of oestrogen receptor expression on needle core biopsy specimens of invasive carcinomas of the breast.
    Hodi Z; Chakrabarti J; Lee AH; Ronan JE; Elston CW; Cheung KL; Robertson JF; Ellis IO
    J Clin Pathol; 2007 Mar; 60(3):299-302. PubMed ID: 16731591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of oestrogen and progesterone receptor status in HER-2 positive breast carcinomas and correlation with outcome.
    Francis G; Beadle G; Thomas S; Mengersen K; Stein S
    Pathology; 2006 Oct; 38(5):391-8. PubMed ID: 17008275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimization and validation of immunocytochemical detection of oestrogen receptors on cytospins prepared from fine needle aspiration (FNA) samples of breast cancer.
    Srebotnik Kirbiš I; Us Krašovec M; Pogačnik A; Strojan Fležar M
    Cytopathology; 2015 Apr; 26(2):88-98. PubMed ID: 24807705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of an evidence-based approach to external quality assurance for breast cancer hormone receptor immunohistochemistry: comparison of reference values.
    Makretsov N; Gilks CB; Alaghehbandan R; Garratt J; Quenneville L; Mercer J; Palavdzic D; Torlakovic EE; ;
    Arch Pathol Lab Med; 2011 Jul; 135(7):874-81. PubMed ID: 21732777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of evaluations for hormone receptors in breast carcinoma using two manual and three automated immunohistochemical assays.
    Arihiro K; Umemura S; Kurosumi M; Moriya T; Oyama T; Yamashita H; Umekita Y; Komoike Y; Shimizu C; Fukushima H; Kajiwara H; Akiyama F
    Am J Clin Pathol; 2007 Mar; 127(3):356-65. PubMed ID: 17276950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunocytochemical evaluation of estrogen receptor on archival Papanicolaou-stained fine-needle aspirate smears.
    Krishnamurthy S; Dimashkieh H; Patel S; Sneige N
    Diagn Cytopathol; 2003 Dec; 29(6):309-14. PubMed ID: 14648786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue microarrays are an effective quality assurance tool for diagnostic immunohistochemistry.
    Hsu FD; Nielsen TO; Alkushi A; Dupuis B; Huntsman D; Liu CL; van de Rijn M; Gilks CB
    Mod Pathol; 2002 Dec; 15(12):1374-80. PubMed ID: 12481020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. External quality assessment for immunohistochemistry: experiences from NordiQC.
    Nielsen S
    Biotech Histochem; 2015 Jul; 90(5):331-40. PubMed ID: 25901597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.